{"transactions":[{"id":962516,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2025-12-19T17:24:49.000Z","date":"2025-12-18","kind":"sale","planned":true,"acquired":false,"shares":30654,"price":38.4959,"value":1180053.3186,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on August 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.31 to $38.67 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001814899-25-000010","document":"wk-form4_1766183086.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000181489925000010/wk-form4_1766183086.xml","form_type":"4"}},{"id":962515,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2025-12-19T17:24:49.000Z","date":"2025-12-17","kind":"sale","planned":true,"acquired":false,"shares":79346,"price":38.5688,"value":3060280.0048,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on August 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.31 to $38.87 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":30654,"source":{"system":"sec-edgar","filing":"0001814899-25-000010","document":"wk-form4_1766183086.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000181489925000010/wk-form4_1766183086.xml","form_type":"4"}},{"id":979639,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2025-12-05T17:01:28.000Z","date":"2025-12-03","kind":"sale","planned":true,"acquired":false,"shares":110000,"price":39.7728,"value":4375008.0,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on August 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.36 to $40.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":110000,"source":{"system":"sec-edgar","filing":"0001814899-25-000008","document":"wk-form4_1764972084.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000181489925000008/wk-form4_1764972084.xml","form_type":"4"}},{"id":991771,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2025-11-21T16:55:37.000Z","date":"2025-11-19","kind":"sale","planned":true,"acquired":false,"shares":230,"price":39.0331,"value":8977.613,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on August 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.79 to $39.34 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001814899-25-000006","document":"wk-form4_1763762134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000181489925000006/wk-form4_1763762134.xml","form_type":"4"}},{"id":991770,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2025-11-21T16:55:37.000Z","date":"2025-11-19","kind":"sale","planned":true,"acquired":false,"shares":2770,"price":38.2858,"value":106051.666,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on August 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.79 to $38.78 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":230,"source":{"system":"sec-edgar","filing":"0001814899-25-000006","document":"wk-form4_1763762134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000181489925000006/wk-form4_1763762134.xml","form_type":"4"}},{"id":991769,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2025-11-21T16:55:37.000Z","date":"2025-11-19","kind":"sale","planned":true,"acquired":false,"shares":2470,"price":39.0067,"value":96346.549,"ownership":{"direct":false,"nature":"By GWL 2021 G, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on August 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.77 to $39.34 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001814899-25-000006","document":"wk-form4_1763762134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000181489925000006/wk-form4_1763762134.xml","form_type":"4"}},{"id":991768,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2025-11-21T16:55:37.000Z","date":"2025-11-19","kind":"sale","planned":true,"acquired":false,"shares":25530,"price":38.2789,"value":977260.317,"ownership":{"direct":false,"nature":"By GWL 2021 G, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on August 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.77 to $38.76 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":2470,"source":{"system":"sec-edgar","filing":"0001814899-25-000006","document":"wk-form4_1763762134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000181489925000006/wk-form4_1763762134.xml","form_type":"4"}},{"id":991767,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2025-11-21T16:55:37.000Z","date":"2025-11-19","kind":"sale","planned":true,"acquired":false,"shares":4599,"price":39.0071,"value":179393.6529,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on August 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.77 to $39.34 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001814899-25-000006","document":"wk-form4_1763762134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000181489925000006/wk-form4_1763762134.xml","form_type":"4"}},{"id":991766,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2025-11-21T16:55:37.000Z","date":"2025-11-19","kind":"sale","planned":true,"acquired":false,"shares":47401,"price":38.2787,"value":1814448.6587,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on August 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.77 to $38.76 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":4599,"source":{"system":"sec-edgar","filing":"0001814899-25-000006","document":"wk-form4_1763762134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000181489925000006/wk-form4_1763762134.xml","form_type":"4"}},{"id":991765,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2025-11-21T16:55:37.000Z","date":"2025-11-19","kind":"sale","planned":true,"acquired":false,"shares":4628,"price":39.0077,"value":180527.6356,"ownership":{"direct":false,"nature":"By GWL 2023 G HoldCo LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on August 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.77 to $39.34 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":6084,"source":{"system":"sec-edgar","filing":"0001814899-25-000006","document":"wk-form4_1763762134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000181489925000006/wk-form4_1763762134.xml","form_type":"4"}},{"id":991764,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2025-11-21T16:55:37.000Z","date":"2025-11-19","kind":"sale","planned":true,"acquired":false,"shares":47798,"price":38.2788,"value":1829650.0824,"ownership":{"direct":false,"nature":"By GWL 2023 G HoldCo LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All reported transactions were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on August 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.77 to $38.76 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":10712,"source":{"system":"sec-edgar","filing":"0001814899-25-000006","document":"wk-form4_1763762134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000181489925000006/wk-form4_1763762134.xml","form_type":"4"}},{"id":1005269,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2025-11-07T16:18:31.000Z","date":"2025-11-05","kind":"grant","planned":false,"acquired":true,"shares":6168,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GWL 2023 G HoldCo LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards."}],"balance_after":58510,"source":{"system":"sec-edgar","filing":"0001814899-25-000003","document":"wk-form4_1762550308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000181489925000003/wk-form4_1762550308.xml","form_type":"4"}},{"id":1071760,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"LP interests in RPI US Partners 2019, LP","published_at":"2025-08-08T16:56:59.000Z","date":"2025-08-08","kind":"gift","planned":false,"acquired":false,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"No limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\") are being exchanged by the Reporting Person. Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") may be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. Any exchanges will be made pursuant to the terms of the Amended and Restated Exchange Agreement. No additional value will be paid by the Reporting Person in connection with an exchange."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001802768-25-000103","document":"wk-form4_1754686616.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000180276825000103/wk-form4_1754686616.xml","form_type":"4"}},{"id":1071759,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2025-08-08T16:56:59.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":3696,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GWL 2023 G HoldCo LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards."}],"balance_after":52342,"source":{"system":"sec-edgar","filing":"0001802768-25-000103","document":"wk-form4_1754686616.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000180276825000103/wk-form4_1754686616.xml","form_type":"4"}},{"id":1141113,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class E Ordinary Shares","published_at":"2025-05-20T16:51:00.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":1944471,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote (1)(2)"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the exempt indirect acquisition by the Reporting Person pursuant to Rule 16b-3 of Class E ordinary shares (\"Class E Shares\") of Royalty Pharma Holdings Ltd (\"RPH\") in connection with the consummation of the transactions contemplated by the Membership Interests Purchase Agreement, dated as of January 10, 2025 (as many be amended from time to time, the \"Purchase Agreement\") between RPH, Royalty Pharma, LLC, RP Management, LLC, the Issuer and certain other parties thereto."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each Class E share will vest in installments over a 9-year period. Once vested, the Class E Shares may be converted at any time into an equivalent number of Class B ordinary shares of RPH (\"Class B Shares\") on a one-for-one basis, and there is no expiration date for such conversion. Each Class B Share may be converted at any time into an equivalent number of Class A ordinary shares of the Issuer on a one-for-one basis and there is no expiration date for such conversion."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each Class E share will vest in installments over a 9-year period. Once vested, the Class E Shares may be converted at any time into an equivalent number of Class B ordinary shares of RPH (\"Class B Shares\") on a one-for-one basis, and there is no expiration date for such conversion. Each Class B Share may be converted at any time into an equivalent number of Class A ordinary shares of the Issuer on a one-for-one basis and there is no expiration date for such conversion."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each Class E share will vest in installments over a 9-year period. Once vested, the Class E Shares may be converted at any time into an equivalent number of Class B ordinary shares of RPH (\"Class B Shares\") on a one-for-one basis, and there is no expiration date for such conversion. Each Class B Share may be converted at any time into an equivalent number of Class A ordinary shares of the Issuer on a one-for-one basis and there is no expiration date for such conversion."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Each Class E share will vest in installments over a 9-year period. Once vested, the Class E Shares may be converted at any time into an equivalent number of Class B ordinary shares of RPH (\"Class B Shares\") on a one-for-one basis, and there is no expiration date for such conversion. Each Class B Share may be converted at any time into an equivalent number of Class A ordinary shares of the Issuer on a one-for-one basis and there is no expiration date for such conversion."}],"balance_after":1944471,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":1944471},"source":{"system":"sec-edgar","filing":"0001802768-25-000065","document":"wk-form4_1747774253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000180276825000065/wk-form4_1747774253.xml","form_type":"4"}},{"id":1154385,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2025-05-09T17:15:40.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":48646,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GWL 2023 G HoldCo LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards."}],"balance_after":48646,"source":{"system":"sec-edgar","filing":"0001802768-25-000037","document":"wk-form4_1746825335.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000180276825000037/wk-form4_1746825335.xml","form_type":"4"}},{"id":1436338,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"LP interests in RPI US Partners 2019, LP","published_at":"2024-08-12T19:19:02.000Z","date":"2024-08-12","kind":"gift","planned":false,"acquired":false,"shares":7920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"No limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\") are being exchanged by the Reporting Person. Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") may be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. Any exchanges will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value will be paid by the Reporting Person in connection with an exchange."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person made a charitable donation of RPI US LP Interests. No Class A Ordinary Shares or RPI US LP Interests were sold."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":79200},"source":{"system":"sec-edgar","filing":"0001802768-24-000049","document":"wk-form4_1723504736.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000180276824000049/wk-form4_1723504736.xml","form_type":"4"}},{"id":1742919,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"LP interests in RPI US Partners 2019, LP","published_at":"2023-11-14T19:35:11.000Z","date":"2023-11-13","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\"). Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value will be paid by the Reporting Person in connection with the exchange."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person has agreed to retain and not sell Class A Ordinary Shares and RPI US LP Interests convertible into Class A Ordinary Shares representing approximately 4,573,096 Class A Ordinary Shares before February 2025 pursuant to an agreement by and between the Reporting Person and RP Management, LLC. This restriction is waivable under certain circumstances."}],"balance_after":162680,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001802768-23-000032","document":"wk-form4_1700008499.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000180276823000032/wk-form4_1700008499.xml","form_type":"4"}},{"id":1742918,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"LP interests in RPI US Partners 2019, LP","published_at":"2023-11-14T19:35:11.000Z","date":"2023-11-13","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\"). Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value will be paid by the Reporting Person in connection with the exchange."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person has agreed to retain and not sell Class A Ordinary Shares and RPI US LP Interests convertible into Class A Ordinary Shares representing approximately 4,573,096 Class A Ordinary Shares before February 2025 pursuant to an agreement by and between the Reporting Person and RP Management, LLC. This restriction is waivable under certain circumstances."}],"balance_after":245299,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001802768-23-000032","document":"wk-form4_1700008499.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000180276823000032/wk-form4_1700008499.xml","form_type":"4"}},{"id":1742917,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2023-11-14T19:35:11.000Z","date":"2023-11-13","kind":"exercise","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\"). Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value will be paid by the Reporting Person in connection with the exchange."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\"). Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value will be paid by the Reporting Person in connection with the exchange."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person has agreed to retain and not sell Class A Ordinary Shares and RPI US LP Interests convertible into Class A Ordinary Shares representing approximately 4,573,096 Class A Ordinary Shares before February 2025 pursuant to an agreement by and between the Reporting Person and RP Management, LLC. This restriction is waivable under certain circumstances."}],"balance_after":220000,"source":{"system":"sec-edgar","filing":"0001802768-23-000032","document":"wk-form4_1700008499.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000180276823000032/wk-form4_1700008499.xml","form_type":"4"}},{"id":1742916,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2023-11-14T19:35:11.000Z","date":"2023-11-13","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\"). Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value will be paid by the Reporting Person in connection with the exchange."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\"). Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value will be paid by the Reporting Person in connection with the exchange."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person has agreed to retain and not sell Class A Ordinary Shares and RPI US LP Interests convertible into Class A Ordinary Shares representing approximately 4,573,096 Class A Ordinary Shares before February 2025 pursuant to an agreement by and between the Reporting Person and RP Management, LLC. This restriction is waivable under certain circumstances."}],"balance_after":80000,"source":{"system":"sec-edgar","filing":"0001802768-23-000032","document":"wk-form4_1700008499.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000180276823000032/wk-form4_1700008499.xml","form_type":"4"}},{"id":1813305,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"LP interests in RPI US Partners 2019, LP","published_at":"2023-08-08T17:36:09.000Z","date":"2023-08-08","kind":"gift","planned":false,"acquired":false,"shares":5555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"No limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\") are being exchanged by the Reporting Person. Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") may be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. Any exchanges will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value will be paid by the Reporting Person in connection with an exchange."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person made a charitable donation of RPI US LP Interests. No Class A Ordinary Shares or RPI US LP Interests were sold."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":55550},"source":{"system":"sec-edgar","filing":"0001209191-23-045063","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919123045063/doc4.xml","form_type":"4"}},{"id":1865652,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2023-06-06T17:07:01.000Z","date":"2023-06-06","kind":"sale","planned":false,"acquired":false,"shares":79099,"price":33.8158,"value":2674795.9642,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.50 to $34.02 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001209191-23-034792","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919123034792/doc4.xml","form_type":"4"}},{"id":1865651,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2023-06-06T17:07:01.000Z","date":"2023-06-05","kind":"sale","planned":false,"acquired":false,"shares":19215,"price":33.5387,"value":644446.1205,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.50 to $33.69 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":109099,"source":{"system":"sec-edgar","filing":"0001209191-23-034792","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919123034792/doc4.xml","form_type":"4"}},{"id":1865650,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2023-06-06T17:07:01.000Z","date":"2023-06-02","kind":"sale","planned":false,"acquired":false,"shares":1686,"price":33.5362,"value":56542.0332,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.53 to $33.55 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":128314,"source":{"system":"sec-edgar","filing":"0001209191-23-034792","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919123034792/doc4.xml","form_type":"4"}},{"id":1865649,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2023-06-06T17:07:01.000Z","date":"2023-06-02","kind":"sale","planned":false,"acquired":false,"shares":92221,"price":33.6453,"value":3102803.2113,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.51 to $33.80 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":120000,"source":{"system":"sec-edgar","filing":"0001209191-23-034792","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919123034792/doc4.xml","form_type":"4"}},{"id":1935227,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2023-03-30T17:52:21.000Z","date":"2023-03-29","kind":"sale","planned":false,"acquired":false,"shares":12779,"price":37.0268,"value":473165.4772,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.75 to $37.31 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":212221,"source":{"system":"sec-edgar","filing":"0001209191-23-021648","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919123021648/doc4.xml","form_type":"4"}},{"id":1935226,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2023-03-30T17:52:21.000Z","date":"2023-03-28","kind":"sale","planned":false,"acquired":false,"shares":100000,"price":37.0613,"value":3706130.0,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.90 to $37.19 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":225000,"source":{"system":"sec-edgar","filing":"0001209191-23-021648","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919123021648/doc4.xml","form_type":"4"}},{"id":1991283,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2023-02-27T19:14:01.000Z","date":"2023-02-23","kind":"sale","acquired":false,"shares":25000,"price":37.2663,"value":931657.5,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.19 to $37.37 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":325000,"source":{"system":"sec-edgar","filing":"0001209191-23-013398","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919123013398/doc4.xml","form_type":"4"}},{"id":2107517,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2022-11-22T17:29:09.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":1900,"price":43.1416,"value":81969.04,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.30 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":350000,"source":{"system":"sec-edgar","filing":"0001209191-22-058450","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919122058450/doc4.xml","form_type":"4"}},{"id":2107516,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2022-11-22T17:29:09.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":14469,"price":43.1874,"value":624878.4906,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.30 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":130000,"source":{"system":"sec-edgar","filing":"0001209191-22-058450","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919122058450/doc4.xml","form_type":"4"}},{"id":2107515,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2022-11-22T17:29:09.000Z","date":"2022-11-21","kind":"sale","acquired":false,"shares":3100,"price":43.109,"value":133637.9,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.20 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":351900,"source":{"system":"sec-edgar","filing":"0001209191-22-058450","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919122058450/doc4.xml","form_type":"4"}},{"id":2107514,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2022-11-22T17:29:09.000Z","date":"2022-11-21","kind":"sale","acquired":false,"shares":20531,"price":43.1095,"value":885081.1445,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.20 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":144469,"source":{"system":"sec-edgar","filing":"0001209191-22-058450","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919122058450/doc4.xml","form_type":"4"}},{"id":2118899,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"LP interests in RPI US Partners 2019, LP","published_at":"2022-11-14T17:13:39.000Z","date":"2022-08-12","kind":"gift","acquired":false,"shares":5889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"No limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\") are being exchanged by the Reporting Person. Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") may be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. Any exchanges will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value will be paid by the Reporting Person in connection with an exchange."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The Reporting Person made a charitable donation of RPI US LP Interests. No Class A Ordinary Shares or RPI US LP Interests were sold."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value."}],"balance_after":0,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":58890},"source":{"system":"sec-edgar","filing":"0001209191-22-056677","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919122056677/doc4.xml","form_type":"4"}},{"id":2118898,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2022-11-14T17:13:39.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":25000,"price":43.8515,"value":1096287.5,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Class A Ordinary Shares sold pursuant to a 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.65 to $43.94 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":355000,"source":{"system":"sec-edgar","filing":"0001209191-22-056677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919122056677/doc4.xml","form_type":"4"}},{"id":2118897,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & CLO"}}],"security":"Class A Ordinary Shares","published_at":"2022-11-14T17:13:39.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":25000,"price":43.853,"value":1096325.0,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Class A Ordinary Shares sold pursuant to a 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.64 to $43.95 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":165000,"source":{"system":"sec-edgar","filing":"0001209191-22-056677","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919122056677/doc4.xml","form_type":"4"}},{"id":2188489,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2022-08-11T17:02:18.000Z","date":"2022-08-10","kind":"sale","acquired":false,"shares":8995,"price":43.9253,"value":395108.0735,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.90 to $44.01 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":201114,"source":{"system":"sec-edgar","filing":"0001209191-22-045451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919122045451/doc4.xml","form_type":"4"}},{"id":2188488,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2022-08-11T17:02:18.000Z","date":"2022-08-09","kind":"sale","acquired":false,"shares":11859,"price":43.9161,"value":520801.0299,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.90 to $43.95 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":210109,"source":{"system":"sec-edgar","filing":"0001209191-22-045451","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919122045451/doc4.xml","form_type":"4"}},{"id":2199426,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2022-08-01T17:01:40.000Z","date":"2022-07-28","kind":"sale","acquired":false,"shares":4046,"price":43.9676,"value":177892.9096,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.91 to $44.01 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":221968,"source":{"system":"sec-edgar","filing":"0001209191-22-043689","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919122043689/doc4.xml","form_type":"4"}},{"id":2201517,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2022-07-27T18:20:16.000Z","date":"2022-07-27","kind":"sale","acquired":false,"shares":100,"price":43.9,"value":4390.0,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"balance_after":226014,"source":{"system":"sec-edgar","filing":"0001209191-22-043286","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919122043286/doc4.xml","form_type":"4"}},{"id":2201516,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2022-07-27T18:20:16.000Z","date":"2022-07-27","kind":"sale","acquired":false,"shares":25000,"price":43.7622,"value":1094055.0,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.70 to $43.89 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":380000,"source":{"system":"sec-edgar","filing":"0001209191-22-043286","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919122043286/doc4.xml","form_type":"4"}},{"id":2201515,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2022-07-27T18:20:16.000Z","date":"2022-07-26","kind":"sale","acquired":false,"shares":13886,"price":43.1243,"value":598824.0298,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.93 to $43.35 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":226114,"source":{"system":"sec-edgar","filing":"0001209191-22-043286","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919122043286/doc4.xml","form_type":"4"}},{"id":2201514,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2022-07-27T18:20:16.000Z","date":"2022-07-26","kind":"sale","acquired":false,"shares":5443,"price":43.0319,"value":234222.6317,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.91 to $43.13 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":405000,"source":{"system":"sec-edgar","filing":"0001209191-22-043286","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919122043286/doc4.xml","form_type":"4"}},{"id":2201513,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2022-07-27T18:20:16.000Z","date":"2022-07-25","kind":"sale","acquired":false,"shares":11114,"price":42.9766,"value":477641.9324,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.90 to $43.17 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":228886,"source":{"system":"sec-edgar","filing":"0001209191-22-043286","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919122043286/doc4.xml","form_type":"4"}},{"id":2201512,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2022-07-27T18:20:16.000Z","date":"2022-07-25","kind":"sale","acquired":false,"shares":19557,"price":42.9036,"value":839065.7052,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.72 to $43.16 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":410443,"source":{"system":"sec-edgar","filing":"0001209191-22-043286","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919122043286/doc4.xml","form_type":"4"}},{"id":2252073,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2022-05-31T17:19:57.000Z","date":"2022-05-27","kind":"sale","acquired":false,"shares":13974,"price":40.7724,"value":569753.5176,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.67 to $40.89 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":430000,"source":{"system":"sec-edgar","filing":"0001209191-22-032900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919122032900/doc4.xml","form_type":"4"}},{"id":2252072,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2022-05-31T17:19:57.000Z","date":"2022-05-26","kind":"sale","acquired":false,"shares":86026,"price":40.2127,"value":3459337.7302,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.26 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":443974,"source":{"system":"sec-edgar","filing":"0001209191-22-032900","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919122032900/doc4.xml","form_type":"4"}},{"id":2257292,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2022-05-25T17:10:27.000Z","date":"2022-05-23","kind":"sale","acquired":false,"shares":100000,"price":40.2677,"value":4026770.0,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.80 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":530000,"source":{"system":"sec-edgar","filing":"0001209191-22-031924","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919122031924/doc4.xml","form_type":"4"}},{"id":2505480,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"LP interests in RPI US Partners 2019, LP","published_at":"2021-11-18T19:18:31.000Z","date":"2021-09-10","kind":"gift","acquired":false,"shares":1282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"No limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\") are being exchanged by the Reporting Person. Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") may be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. Any exchanges will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value will be paid by the Reporting Person in connection with an exchange."},{"field":"kind","element":"transactionCoding","label":"F6","text":"The Reporting Person made a charitable donation of RPI US LP Interests. No Class A Ordinary Shares or RPI US LP Interests were sold."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"The Reporting Person has agreed to retain and not sell Class A Ordinary Shares and RPI US LP Interests convertible into Class A Ordinary Shares representing approximately 7,397,096 Class A Ordinary Shares before February 2025 pursuant to an agreement by and between the Reporting Person and RP Management, LLC. This restriction is waivable under certain circumstances."}],"balance_after":5889,"derivative":{"underlying":"Class A Ordinary Shares","underlying_shares":12820},"source":{"system":"sec-edgar","filing":"0001209191-21-065639","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919121065639/doc4.xml","form_type":"4"}},{"id":2505479,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-11-18T19:18:31.000Z","date":"2021-11-17","kind":"sale","acquired":false,"shares":84148,"price":42.3876,"value":3566831.7648,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.92 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":630000,"source":{"system":"sec-edgar","filing":"0001209191-21-065639","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919121065639/doc4.xml","form_type":"4"}},{"id":2505478,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-11-18T19:18:31.000Z","date":"2021-11-16","kind":"sale","acquired":false,"shares":65852,"price":42.1196,"value":2773659.8992,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.29 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":714148,"source":{"system":"sec-edgar","filing":"0001209191-21-065639","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919121065639/doc4.xml","form_type":"4"}},{"id":2505477,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-11-18T19:18:31.000Z","date":"2021-11-16","kind":"sale","acquired":false,"shares":27341,"price":43.1887,"value":1180822.2467,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.60 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":495860,"source":{"system":"sec-edgar","filing":"0001209191-21-065639","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919121065639/doc4.xml","form_type":"4"}},{"id":2505476,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-11-18T19:18:31.000Z","date":"2021-11-16","kind":"sale","acquired":false,"shares":72659,"price":42.3262,"value":3075379.3658,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.98 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":523201,"source":{"system":"sec-edgar","filing":"0001209191-21-065639","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919121065639/doc4.xml","form_type":"4"}},{"id":2624373,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-07-27T17:29:09.000Z","date":"2021-07-26","kind":"sale","acquired":false,"shares":8449,"price":39.7611,"value":335941.5339,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.56 to $40.21 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":780000,"source":{"system":"sec-edgar","filing":"0001209191-21-048317","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919121048317/doc4.xml","form_type":"4"}},{"id":2624372,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-07-27T17:29:09.000Z","date":"2021-07-26","kind":"sale","acquired":false,"shares":4913,"price":39.8109,"value":195590.9517,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.57 to $40.21 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":595860,"source":{"system":"sec-edgar","filing":"0001209191-21-048317","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000120919121048317/doc4.xml","form_type":"4"}},{"id":2634347,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-07-14T17:18:40.000Z","date":"2021-07-13","kind":"sale","acquired":false,"shares":17981,"price":42.0089,"value":755362.0309,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":788449,"source":{"system":"sec-edgar","filing":"0000899243-21-028335","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000089924321028335/doc4.xml","form_type":"4"}},{"id":2634346,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-07-14T17:18:40.000Z","date":"2021-07-13","kind":"sale","acquired":false,"shares":5068,"price":42.0067,"value":212889.9556,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":600773,"source":{"system":"sec-edgar","filing":"0000899243-21-028335","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000089924321028335/doc4.xml","form_type":"4"}},{"id":2634345,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-07-14T17:18:40.000Z","date":"2021-07-12","kind":"sale","acquired":false,"shares":100,"price":42.04,"value":4204.0,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"balance_after":806430,"source":{"system":"sec-edgar","filing":"0000899243-21-028335","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000089924321028335/doc4.xml","form_type":"4"}},{"id":2638767,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-07-08T19:36:12.000Z","date":"2021-07-08","kind":"sale","acquired":false,"shares":40667,"price":42.0464,"value":1709900.9488,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.21 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":806530,"source":{"system":"sec-edgar","filing":"0000950103-21-010244","document":"dp154126_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321010244/dp154126_4-lloyd.xml","form_type":"4"}},{"id":2638766,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-07-08T19:36:12.000Z","date":"2021-07-08","kind":"sale","acquired":false,"shares":8392,"price":42.0505,"value":352887.796,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.21 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":605841,"source":{"system":"sec-edgar","filing":"0000950103-21-010244","document":"dp154126_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321010244/dp154126_4-lloyd.xml","form_type":"4"}},{"id":2638765,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-07-08T19:36:12.000Z","date":"2021-07-07","kind":"sale","acquired":false,"shares":2500,"price":42.0088,"value":105022.0,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.03 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":847197,"source":{"system":"sec-edgar","filing":"0000950103-21-010244","document":"dp154126_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321010244/dp154126_4-lloyd.xml","form_type":"4"}},{"id":2638764,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-07-08T19:36:12.000Z","date":"2021-07-07","kind":"sale","acquired":false,"shares":400,"price":42.015,"value":16806.0,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.01 to $42.02 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":614233,"source":{"system":"sec-edgar","filing":"0000950103-21-010244","document":"dp154126_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321010244/dp154126_4-lloyd.xml","form_type":"4"}},{"id":2638763,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-07-08T19:36:12.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":30303,"price":42.4059,"value":1285025.9877,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.84 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":849697,"source":{"system":"sec-edgar","filing":"0000950103-21-010244","document":"dp154126_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321010244/dp154126_4-lloyd.xml","form_type":"4"}},{"id":2638762,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-07-08T19:36:12.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":6227,"price":42.4151,"value":264118.8277,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.04 to $42.88 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":614633,"source":{"system":"sec-edgar","filing":"0000950103-21-010244","document":"dp154126_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321010244/dp154126_4-lloyd.xml","form_type":"4"}},{"id":2670849,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-06-14T18:42:39.000Z","date":"2021-06-10","kind":"sale","acquired":false,"shares":10000,"price":46.4491,"value":464491.0,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.40 to $46.65 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":240000,"source":{"system":"sec-edgar","filing":"0000950103-21-008761","document":"dp152652_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321008761/dp152652_4-lloyd.xml","form_type":"4"}},{"id":2670848,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-06-14T18:42:39.000Z","date":"2021-06-10","kind":"sale","acquired":false,"shares":40000,"price":46.5193,"value":1860772.0,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.40 to $46.69 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":880000,"source":{"system":"sec-edgar","filing":"0000950103-21-008761","document":"dp152652_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321008761/dp152652_4-lloyd.xml","form_type":"4"}},{"id":2670847,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-06-14T18:42:39.000Z","date":"2021-06-10","kind":"sale","acquired":false,"shares":20000,"price":46.4553,"value":929106.0,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.40 to $46.66 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":620860,"source":{"system":"sec-edgar","filing":"0000950103-21-008761","document":"dp152652_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321008761/dp152652_4-lloyd.xml","form_type":"4"}},{"id":2678279,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-06-08T20:12:49.000Z","date":"2021-06-08","kind":"sale","acquired":false,"shares":10000,"price":46.4747,"value":464747.0,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.40 to $46.70 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":250000,"source":{"system":"sec-edgar","filing":"0000950103-21-008571","document":"dp152452_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321008571/dp152452_4-lloyd.xml","form_type":"4"}},{"id":2678278,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-06-08T20:12:49.000Z","date":"2021-06-08","kind":"sale","acquired":false,"shares":40000,"price":46.4836,"value":1859344.0,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.40 to $46.69 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":920000,"source":{"system":"sec-edgar","filing":"0000950103-21-008571","document":"dp152452_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321008571/dp152452_4-lloyd.xml","form_type":"4"}},{"id":2678277,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-06-08T20:12:49.000Z","date":"2021-06-08","kind":"sale","acquired":false,"shares":20000,"price":46.477,"value":929540.0,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.40 to $46.67 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":640860,"source":{"system":"sec-edgar","filing":"0000950103-21-008571","document":"dp152452_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321008571/dp152452_4-lloyd.xml","form_type":"4"}},{"id":2678276,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-06-08T20:12:49.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":4853,"price":46.5401,"value":225859.1053,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.44 to $46.67 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":260000,"source":{"system":"sec-edgar","filing":"0000950103-21-008571","document":"dp152452_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321008571/dp152452_4-lloyd.xml","form_type":"4"}},{"id":2678275,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-06-08T20:12:49.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":15147,"price":45.8909,"value":695109.4623,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.50 to $46.34 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":264853,"source":{"system":"sec-edgar","filing":"0000950103-21-008571","document":"dp152452_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321008571/dp152452_4-lloyd.xml","form_type":"4"}},{"id":2678274,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-06-08T20:12:49.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":36619,"price":46.7434,"value":1711696.5646,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.50 to $47.07 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":960000,"source":{"system":"sec-edgar","filing":"0000950103-21-008571","document":"dp152452_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321008571/dp152452_4-lloyd.xml","form_type":"4"}},{"id":2678273,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-06-08T20:12:49.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":33381,"price":46.0971,"value":1538767.2951,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.50 to $46.49 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":996619,"source":{"system":"sec-edgar","filing":"0000950103-21-008571","document":"dp152452_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321008571/dp152452_4-lloyd.xml","form_type":"4"}},{"id":2678272,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-06-08T20:12:49.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":13400,"price":46.7701,"value":626719.34,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.50 to $47.06 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":660860,"source":{"system":"sec-edgar","filing":"0000950103-21-008571","document":"dp152452_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321008571/dp152452_4-lloyd.xml","form_type":"4"}},{"id":2678271,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-06-08T20:12:49.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":19100,"price":45.9726,"value":878076.66,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.50 to $46.48 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":674260,"source":{"system":"sec-edgar","filing":"0000950103-21-008571","document":"dp152452_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321008571/dp152452_4-lloyd.xml","form_type":"4"}},{"id":2678270,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-06-08T20:12:49.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":20000,"price":44.8102,"value":896204.0,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.72 to $44.89 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":280000,"source":{"system":"sec-edgar","filing":"0000950103-21-008571","document":"dp152452_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321008571/dp152452_4-lloyd.xml","form_type":"4"}},{"id":2678269,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-06-08T20:12:49.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":20000,"price":44.8514,"value":897028.0,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.53 to $45.06 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1030000,"source":{"system":"sec-edgar","filing":"0000950103-21-008571","document":"dp152452_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321008571/dp152452_4-lloyd.xml","form_type":"4"}},{"id":2678268,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-06-08T20:12:49.000Z","date":"2021-06-04","kind":"sale","acquired":false,"shares":20000,"price":44.6853,"value":893706.0,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.15 to $45.04 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":693360,"source":{"system":"sec-edgar","filing":"0000950103-21-008571","document":"dp152452_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321008571/dp152452_4-lloyd.xml","form_type":"4"}},{"id":2681696,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-06-04T18:48:53.000Z","date":"2021-06-02","kind":"sale","acquired":false,"shares":50000,"price":42.1277,"value":2106385.0,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.56 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1050000,"source":{"system":"sec-edgar","filing":"0000950103-21-008456","document":"dp152316_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321008456/dp152316_4-lloyd.xml","form_type":"4"}},{"id":2681695,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-06-04T18:48:53.000Z","date":"2021-06-02","kind":"sale","acquired":false,"shares":12500,"price":42.0902,"value":526127.5,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.26 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":713360,"source":{"system":"sec-edgar","filing":"0000950103-21-008456","document":"dp152316_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321008456/dp152316_4-lloyd.xml","form_type":"4"}},{"id":2719359,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"LP interests in RPI US Partners 2019, LP","published_at":"2021-05-11T21:05:19.000Z","date":"2021-05-07","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\"). Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value will be paid by the Reporting Person in connection with the exchange."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person has agreed to retain and not sell Class A Ordinary Shares and RPI US LP Interests convertible into Class A Ordinary Shares representing approximately 4,573,090 Class A Ordinary Shares before February 2025 pursuant to an agreement by and between the Reporting Person and RP Management, LLC. This restriction is waivable under certain circumstances."}],"balance_after":264027,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000950103-21-007076","document":"dp150858_4-lloyd.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321007076/dp150858_4-lloyd.xml","form_type":"4"}},{"id":2719358,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"LP interests in RPI US Partners 2019, LP","published_at":"2021-05-11T21:05:19.000Z","date":"2021-05-07","kind":"exercise","acquired":false,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\"). Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value will be paid by the Reporting Person in connection with the exchange."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person has agreed to retain and not sell Class A Ordinary Shares and RPI US LP Interests convertible into Class A Ordinary Shares representing approximately 4,573,090 Class A Ordinary Shares before February 2025 pursuant to an agreement by and between the Reporting Person and RP Management, LLC. This restriction is waivable under certain circumstances."}],"balance_after":172680,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0000950103-21-007076","document":"dp150858_4-lloyd.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321007076/dp150858_4-lloyd.xml","form_type":"4"}},{"id":2719357,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"LP interests in RPI US Partners 2019, LP","published_at":"2021-05-11T21:05:19.000Z","date":"2021-05-07","kind":"exercise","acquired":false,"shares":67586,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\"). Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value will be paid by the Reporting Person in connection with the exchange."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":675860},"source":{"system":"sec-edgar","filing":"0000950103-21-007076","document":"dp150858_4-lloyd.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321007076/dp150858_4-lloyd.xml","form_type":"4"}},{"id":2719356,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-05-11T21:05:19.000Z","date":"2021-05-07","kind":"exercise","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GWL 2020 G, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\"). Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value will be paid by the Reporting Person in connection with the exchange."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\"). Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value will be paid by the Reporting Person in connection with the exchange."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person has agreed to retain and not sell Class A Ordinary Shares and RPI US LP Interests convertible into Class A Ordinary Shares representing approximately 4,573,090 Class A Ordinary Shares before February 2025 pursuant to an agreement by and between the Reporting Person and RP Management, LLC. This restriction is waivable under certain circumstances."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0000950103-21-007076","document":"dp150858_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321007076/dp150858_4-lloyd.xml","form_type":"4"}},{"id":2719355,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-05-11T21:05:19.000Z","date":"2021-05-07","kind":"exercise","acquired":true,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\"). Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value will be paid by the Reporting Person in connection with the exchange."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\"). Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value will be paid by the Reporting Person in connection with the exchange."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person has agreed to retain and not sell Class A Ordinary Shares and RPI US LP Interests convertible into Class A Ordinary Shares representing approximately 4,573,090 Class A Ordinary Shares before February 2025 pursuant to an agreement by and between the Reporting Person and RP Management, LLC. This restriction is waivable under certain circumstances."}],"balance_after":1100000,"source":{"system":"sec-edgar","filing":"0000950103-21-007076","document":"dp150858_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321007076/dp150858_4-lloyd.xml","form_type":"4"}},{"id":2719354,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-05-11T21:05:19.000Z","date":"2021-05-07","kind":"exercise","acquired":true,"shares":675860,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\"). Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value will be paid by the Reporting Person in connection with the exchange."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\"). Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value will be paid by the Reporting Person in connection with the exchange."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person has agreed to retain and not sell Class A Ordinary Shares and RPI US LP Interests convertible into Class A Ordinary Shares representing approximately 4,573,090 Class A Ordinary Shares before February 2025 pursuant to an agreement by and between the Reporting Person and RP Management, LLC. This restriction is waivable under certain circumstances."}],"balance_after":725860,"source":{"system":"sec-edgar","filing":"0000950103-21-007076","document":"dp150858_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321007076/dp150858_4-lloyd.xml","form_type":"4"}},{"id":2747693,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-04-16T17:57:01.000Z","date":"2021-04-14","kind":"sale","acquired":false,"shares":55898,"price":42.139,"value":2355485.822,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.41 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0000950103-21-005664","document":"dp149489_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321005664/dp149489_4-lloyd.xml","form_type":"4"}},{"id":2747692,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-04-16T17:57:01.000Z","date":"2021-04-14","kind":"sale","acquired":false,"shares":13924,"price":42.1168,"value":586434.3232,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.40 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0000950103-21-005664","document":"dp149489_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321005664/dp149489_4-lloyd.xml","form_type":"4"}},{"id":2749860,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-04-14T07:52:45.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":360,"price":42.32,"value":15235.2,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"balance_after":255898,"source":{"system":"sec-edgar","filing":"0000950103-21-005530","document":"dp149384_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321005530/dp149384_4-lloyd.xml","form_type":"4"}},{"id":2749859,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-04-14T07:52:45.000Z","date":"2021-04-12","kind":"sale","acquired":false,"shares":89,"price":42.32,"value":3766.48,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"balance_after":63924,"source":{"system":"sec-edgar","filing":"0000950103-21-005530","document":"dp149384_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321005530/dp149384_4-lloyd.xml","form_type":"4"}},{"id":2773700,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-03-24T17:25:11.000Z","date":"2021-03-22","kind":"sale","acquired":false,"shares":100,"price":47.04,"value":4704.0,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"balance_after":256258,"source":{"system":"sec-edgar","filing":"0000950103-21-004521","document":"dp147364_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321004521/dp147364_4-lloyd.xml","form_type":"4"}},{"id":2773699,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-03-24T17:25:11.000Z","date":"2021-03-22","kind":"sale","acquired":false,"shares":43642,"price":46.3186,"value":2021436.3412,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.025 to $47.01 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":256358,"source":{"system":"sec-edgar","filing":"0000950103-21-004521","document":"dp147364_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321004521/dp147364_4-lloyd.xml","form_type":"4"}},{"id":2773698,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-03-24T17:25:11.000Z","date":"2021-03-22","kind":"sale","acquired":false,"shares":10987,"price":46.3353,"value":509085.9411,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.04 to $46.98 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":64013,"source":{"system":"sec-edgar","filing":"0000950103-21-004521","document":"dp147364_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321004521/dp147364_4-lloyd.xml","form_type":"4"}},{"id":2809858,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-03-04T19:03:50.000Z","date":"2021-03-02","kind":"sale","acquired":false,"shares":3510,"price":47.8484,"value":167947.884,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.56 to $48.05 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0000950103-21-003570","document":"dp147384_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321003570/dp147384_4-lloyd.xml","form_type":"4"}},{"id":2809857,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-03-04T19:03:50.000Z","date":"2021-03-02","kind":"sale","acquired":false,"shares":96490,"price":46.8895,"value":4524367.855,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.56 to $47.55 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":303510,"source":{"system":"sec-edgar","filing":"0000950103-21-003570","document":"dp147384_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321003570/dp147384_4-lloyd.xml","form_type":"4"}},{"id":2809856,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-03-04T19:03:50.000Z","date":"2021-03-02","kind":"sale","acquired":false,"shares":2625,"price":47.838,"value":125574.75,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.55 to $48.05 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0000950103-21-003570","document":"dp147384_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321003570/dp147384_4-lloyd.xml","form_type":"4"}},{"id":2809855,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"Class A Ordinary Shares","published_at":"2021-03-04T19:03:50.000Z","date":"2021-03-02","kind":"sale","acquired":false,"shares":22375,"price":46.8942,"value":1049257.725,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.54 to $47.50 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":77625,"source":{"system":"sec-edgar","filing":"0000950103-21-003570","document":"dp147384_4-lloyd.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321003570/dp147384_4-lloyd.xml","form_type":"4"}},{"id":2922984,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"LP interests in RPI US Partners 2019, LP","published_at":"2021-01-05T21:43:57.000Z","date":"2020-12-31","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GWL 2014 G, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\"). Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed was exchanged for one Class A Ordinary Share of the Issuer. This exchange was made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value was paid by the Reporting Person in connection with the exchange."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes RPI US LP Interests convertible into 4,573,096 Class A Ordinary Shares that are subject to an agreement by and between the reporting person and RP Management, LLC under which the reporting person has agreed to retain and not sell such interests before February 2025. This restriction is waivable under certain circumstances."}],"balance_after":556707,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0000950103-21-000104","document":"dp143909_4-lloyd.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321000104/dp143909_4-lloyd.xml","form_type":"4"}},{"id":2922983,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":71137,"kind":"person","name":"Lloyd George W.","position":1,"cik":"0001814899","reported_name":"Lloyd George W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Investments & GC"}}],"security":"LP interests in RPI US Partners 2019, LP","published_at":"2021-01-05T21:43:57.000Z","date":"2020-12-31","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By GWL 2013 NG, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP (\"RPI US LP\"). Each limited partnership interest in RPI US LP (\"RPI US LP Interest\") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited (\"Holdings\"). Each Class B Interest in Holdings so distributed was exchanged for one Class A Ordinary Share of the Issuer. This exchange was made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the \"Exchange Agreement\"). No additional value was paid by the Reporting Person in connection with the exchange."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes RPI US LP Interests convertible into 60,520 Class A Ordinary Shares that are subject to forfeiture if and when the Class A Ordinary Shares attain a 20-trading day volume weighted average price of $32.30 or more after December 15, 2020 and on or before December 15, 2023. The amount of this forfeiture scales linearly from 0% at $20.51 per share to 100% at $32.30 per share."}],"balance_after":73638,"derivative":{"exercise_price":0,"underlying":"Class A Ordinary Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950103-21-000104","document":"dp143909_4-lloyd.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1814899/000095010321000104/dp143909_4-lloyd.xml","form_type":"4"}}],"next_cursor":"2021-01-05T21:43:57.000000Z,2922983"}